ROYCE & ASSOCIATES LP - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 325 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.44 and the average weighting 0.4%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$761,643
+65.4%
12,711
+99.0%
0.01%
+100.0%
Q2 2023$460,431
+879.6%
6,386
+1319.1%
0.00%
Q4 2019$47,000
-19.0%
450
-22.1%
0.00%
-100.0%
Q3 2019$58,000
+56.8%
578
+80.6%
0.00%
Q2 2019$37,000
-2.6%
320
+6.7%
0.00%
Q1 2019$38,000
-97.7%
300
-97.5%
0.00%
-100.0%
Q4 2018$1,628,000
+16180.0%
12,000
+17042.9%
0.02%
Q4 2017$10,000
+25.0%
70
+12.9%
0.00%
Q3 2017$8,000620.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Knott David M Jr 115,000$6,8912.63%
VILLERE ST DENIS J & CO LLC 438,161$26,254,6072.24%
RICE HALL JAMES & ASSOCIATES, LLC 282,961$16,955,0231.08%
Chicago Capital, LLC 360,345$21,591,8841.01%
CARDINAL CAPITAL MANAGEMENT LLC /CT 206,399$12,367,4280.53%
Smith, Graham & Co., Investment Advisors, LP 61,849$3,705,9920.46%
Stephens Investment Management Group LLC 467,564$28,016,4350.46%
Jackson Creek Investment Advisors LLC 13,657$8180.34%
Court Place Advisors, LLC 15,133$906,7690.32%
Ziegler Capital Management, LLC 123,158$7,379,1760.30%
View complete list of LIGAND PHARMACEUTICALS INC shareholders